Kurma Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kurma diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kurma Diagnostics Today - Breaking & Trending Today

Ganymed Robotics Raises €21M to Complete the Development of Its Next Generation Surgical Robot and Prepare for a Commercial Launch

Ganymed Robotics Raises €21M to Complete the Development of Its Next Generation Surgical Robot and Prepare for a Commercial Launch
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , France General , United Kingdom , City Of , San Francisco , Steve Oesterle , Sophie Cahen , Kurma Biofund , Mutuel Alliance , Garnier Co , Cathay Health , Venture Partner At Cathay Health , Mutuel Innovation , Kurma Partners , Ganymed Robotics , Venture Partner , French Tech Emergence , Deep Tech Pioneer , Cathay Capital , North America , Mutuel Equity , Kurma Diagnostics , Kurma Growth Opportunities ,

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman


Share this article
Share this article
MADRID, Feb. 10, 2021 /PRNewswire/ MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II. Having achieved pre-clinical feasibility in 2020, these proceeds will now enable MedLumics to initiate first in-human regulatory clinical studie ....

Comunidad Autonoma De Cataluna , Comunidad Autonoma De Aragon , Olivier Litzka , Prnewswire Medlumics , James Greene , Peter Neubeck , Kurma Biofund , University Of South Florida , Medlumics Ireland Ltd , Sabadell Asabys Health Innovation Investments , European Fund For Strategic Investments , Its Life Sciences , Stanford Biodesign Emerging Entrepreneurs Forum , Stanford Coulter Foundation For Translational Medicine , Ashland University , European Union , Life Sciences , Vi Partners Swiss Innovation Fund , Atrial Fibrillation , Erich Ferrari , Asabys Partners , Swiss Innovation , Andera Partners , Caixa Capital Risc , Innogest Capital , Managing Director ,